We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.50 | 0.21% | 1,644.00 | 1,644.00 | 1,644.50 | 1,647.00 | 1,635.00 | 1,638.50 | 195,653 | 08:38:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.71 | 67.54B |
TIDMGSK
RNS Number : 0289H
GlaxoSmithKline PLC
12 November 2018
GlaxoSmithKline plc
Blocklisting Application
Application has been made to the Financial Conduct Authority and the London Stock Exchange Plc for a total of 5,575,000 Ordinary shares of 25p each ('Shares') to be admitted to the Official List.
These Shares are being reserved under block listings and will be issued as a result of the award of Shares pursuant to the following schemes:
Scheme Shares GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan 575,000 ---------- GlaxoSmithKline plc Sharesave plan 2012 5,000,000 ----------
When issued, these shares will rank pari passu with the existing Shares.
Victoria Whyte
Company Secretary
12 November 2018
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ALSFFMSAEFASEDF
(END) Dow Jones Newswires
November 12, 2018 04:00 ET (09:00 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions